Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

482 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Timing of Complete Multivessel Revascularization in Patients Presenting With Non-ST-Segment Elevation Acute Coronary Syndrome.
Elscot JJ, Kakar H, Scarparo P, den Dekker WK, Bennett J, Schotborgh CE, van der Schaaf R, Sabaté M, Moreno R, Ameloot K, van Bommel RJ, Forlani D, Van Reet B, Esposito G, Dirksen MT, Ruifrok WPT, Everaert BRC, Van Mieghem C, Pinar E, Alfonso F, Cummins P, Lenzen M, Brugaletta S, Daemen J, Boersma E, Van Mieghem NM, Diletti R; BIOVASC Investigators. Elscot JJ, et al. Among authors: daemen j. JACC Cardiovasc Interv. 2024 Mar 25;17(6):771-782. doi: 10.1016/j.jcin.2024.01.278. JACC Cardiovasc Interv. 2024. PMID: 38538172 Free article. Clinical Trial.
Mid- to Long-Term Clinical Outcomes of Patients Treated With the Everolimus-Eluting Bioresorbable Vascular Scaffold: The BVS Expand Registry.
Felix CM, Fam JM, Diletti R, Ishibashi Y, Karanasos A, Everaert BR, van Mieghem NM, Daemen J, de Jaegere PP, Zijlstra F, Regar ES, Onuma Y, van Geuns RJ. Felix CM, et al. Among authors: daemen j. JACC Cardiovasc Interv. 2016 Aug 22;9(16):1652-63. doi: 10.1016/j.jcin.2016.04.035. Epub 2016 Jul 27. JACC Cardiovasc Interv. 2016. PMID: 27476094 Free article.
Routine Fractional Flow Reserve Measurement After Percutaneous Coronary Intervention.
van Bommel RJ, Masdjedi K, Diletti R, Lemmert ME, van Zandvoort L, Wilschut J, Zijlstra F, de Jaegere P, Daemen J, van Mieghem NM. van Bommel RJ, et al. Among authors: daemen j. Circ Cardiovasc Interv. 2019 May;12(5):e007428. doi: 10.1161/CIRCINTERVENTIONS.118.007428. Circ Cardiovasc Interv. 2019. PMID: 31018666
Long-term outcome in patients treated with first- versus second-generation drug-eluting stents for the treatment of unprotected left main coronary artery stenosis.
van Zandvoort LJC, van Bommel RJ, Masdjedi K, Tovar Forero MN, Lemmert MM, Wilschut J, Diletti R, de Jaegere PPT, Zijlstra F, van Mieghem NM, Daemen J. van Zandvoort LJC, et al. Among authors: daemen j. Catheter Cardiovasc Interv. 2020 May 1;95(6):1085-1091. doi: 10.1002/ccd.28387. Epub 2019 Jul 13. Catheter Cardiovasc Interv. 2020. PMID: 31301161
Revascularization Strategies in Patients Presenting With ST-Elevation Myocardial Infarction and Multivessel Coronary Disease.
Tovar Forero MN, Scarparo P, den Dekker W, Balbi M, Masdjedi K, van Zandvoort L, Kardys I, Ameloot K, Daemen J, Lemmert M, Wilschut J, de Jaegere P, Zijlstra F, Van Mieghem N, Diletti R. Tovar Forero MN, et al. Among authors: daemen j. Am J Cardiol. 2020 May 15;125(10):1486-1491. doi: 10.1016/j.amjcard.2020.01.050. Epub 2020 Feb 19. Am J Cardiol. 2020. PMID: 32200948
Percutaneous complete revascularization strategies using sirolimus-eluting biodegradable polymer-coated stents in patients presenting with acute coronary syndrome and multivessel disease: Rationale and design of the BIOVASC trial.
den Dekker WK, Van Mieghem NM, Bennett J, Sabate M, Esposito G, van Bommel RJ, Daemen J, Vrolix M, Cummins PA, Lenzen MJ, Boersma E, Zijlstra F, Diletti R; BioVasc Trial Investigators. den Dekker WK, et al. Among authors: daemen j. Am Heart J. 2020 Sep;227:111-117. doi: 10.1016/j.ahj.2020.06.006. Epub 2020 Jun 15. Am Heart J. 2020. PMID: 32739537 Free article.
482 results